Anticancer and bioactivity effect of the AraA-IL13 fusion protein on the glioblastoma cell line
Background and purpose: Glioblastoma (GBM) is an aggressive and malignant brain cancer with the highest mortality and low survival rates. To discover a more specific and efficient treatment for GBM, we synthesized and examined the cytotoxic effect of arazyme-interleukin-13 (Ara-IL13) fusion protein...
Spremljeno u:
Glavni autori: | , , , , |
---|---|
Format: | Knjiga |
Izdano: |
Wolters Kluwer Medknow Publications,
2024-08-01T00:00:00Z.
|
Teme: | |
Online pristup: | Connect to this object online. |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
Internet
Connect to this object online.3rd Floor Main Library
Signatura: |
A1234.567 |
---|---|
Primjerak 1 | Dostupno |